Lnc2Cancer

Experimentally Supported Human LncRNA and Cancer Associations Database

LncRNA centric

Cancer centric

Advanced search

Drug resistant

Circulating

Prognosis

Detail


   LncRNA Name DLEU2
   Synonyms DLEU1, BCMS, BCMS1, DLB1, DLEU2, LEU1, LEU2, LINC00021, NCRNA00021, XTP6
   Region GRCh38_13:49982552-50125720    Sequence
   Ensembl ENSG00000231607
   RefSeq NR_002612
   Circulating
   Drug-resisitant
   Prognostic
   MiRNA
   Variant
   TF
   Methylation
   Cancer Name chronic lymphocytic leukemia
   ICD-0-3  M9823/3
   Methods qPCR, Northern blot etc.
   Sample cell lines (I83E95)
   Expression Pattern down-regulated
   Function Description

Here, we demonstrate that deletion in mice of the 13q14-minimal deleted region (MDR), which encodes the DLEU2/miR-15a/16-1 cluster, causes development of indolent B cell-autonomous, clonal lymphoproliferative disorders, recapitulating the spectrum of CLL-associated phenotypes observed in humans. miR-15a/16-1-deletion accelerates the proliferation of both human and mouse B cells by modulating the expression of genes controlling cell-cycle progression.

   Pubmed ID 20060366
   Year 2010
   Title The DLEU2/miR-15a/16-1 cluster controls B cell proliferation and its deletion leads to chronic lymphocytic leukemia.
   External Links
   Links for  DLEU2 GenBank       HGNC       lncrnadb       Noncode
   Links for  chronic lymphocytic leukemia Omim       Cosmic

CopyRight © College of Bioinformatics Science and Technology, Harbin Medical University, China.